Long

Antares Pharma Announces Positive Results From Phase I Study For

76
ATRS: Antares Pharma, Inc.
2022-01-11 07:30:00
Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.